From 1990 to 1998 I was employed on a grant from a private foundation (Howard Foundation, Cambridge) and led a team of five through a variety of clinical studies designed to investigate the roles of natural antioxidants and environmental risk factors in health and disease (principally coronary artery disease).  Some of the work had commercial implications, which led to the participation in several radio interviews, press releases, and patents.

Since arriving in UCL in 1998 I have been responsible for the co-ordination of phase III breast cancer trials run in collaboration with industry, and a translational research study.  I have been appointed as a member of international steering committees, a data monitoring committee, and several smaller groups.  Additional responsibilities include development of new trials, writing grant applications and IRAS submissions, management and oversight of adherence to research governance, provision of expertise in trial management including long-term follow-up, initiating and performing other research activities, training, staff management and development, writing publications and presenting data at scientific meetings and seminars, refereeing manuscripts and grant applications.

The portfolio of studies has recently expanded to include prostate cancer, hepato-pancreatico-biliary disease and liver transplantation. The theme is generally “surgeon led” clinical studies.